Users Stopping Weight-Loss Jabs Put On Weight Four Times Faster Compared to Those on Conventional Diets

Fresh analysis suggests that people who come off popular weight-loss injections like Mounjaro or Wegovy tend to recover reduced body mass far faster than those who halt conventional lifestyle regimens.

Research printed in a leading health publication points out that while obese people frequently drop about a fifth of their total mass while undergoing treatment, the mass is regained at an estimated rate of 0.8 kg per month upon discontinuation.

"Individuals buying these drugs should be cognizant of the danger of fast weight regain when the medication is stopped," stated lead investigator Dr. Susan Jebb.

That rate of regain suggests a reversion to starting weight within about 18 months.

Weighing Approaches

The analysis, which reviewed 37 of studies involving thousands of patients, compared the outcomes of the injectable medications with conventional dieting.

The team note that people who lose weight through dieting generally experience a more gradual weight regain—perhaps 0.1 kg a month—after stopping.

Understanding the Fast Rebound

Experts suggest the way of the jabs explains the accelerated rebound.

These medications mimic a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.

"Artificially providing the hormone levels far above than the body's typical production might result in the system to produce less of its endogenous GLP-1, and may also diminish sensitivity to its effects," noted Dr. Adam Collins, a dietetics specialist.

"Stopping of this GLP-1 'fix' results in hunger is uncontrolled, making binge eating far more likely."

A Lifelong Condition?

The NHS recommend the injections for people with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.

A number of clinicians say that, due to the likelihood of weight regain, the therapy might need to be long-term.

This perspective is supported by drug manufacturers, who state that the findings "underscore the persistent nature of excess weight," similar to managing conditions like hypertension.

Patient Testimonies

People who have discontinued the jabs describe a intense resurgence of hunger.

"It felt as if a trigger activating and you're instantly extremely hungry," said an individual.

This difficulty is worsened if individuals have not established sustainable dietary or behavioural changes during treatment.

Significant Adoption

Figures show that millions of people in the UK have used these injections in the last 12 months, with desire being substantial.

• Use is greater among women than males.
• The middle-aged demographic shows the highest usage rates.
• A large proportion obtain the medications through private healthcare rather than the NHS.

Finally, researchers stress that while GLP-1 drugs are potent tools for weight loss, they are not a permanent fix and lasting health benefits hinges on integrated behavioural support.